Balto Therapeutics
New York, US · Founded 2016 · Delaware LLC
Founders & leadership
CB
Courtney BondNamed on SEC filing
TE
Thomas E. FernandezNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2017
▶$3MraisedOct 2017 · 8 investors · PharmaceuticalsRule 506(b)
▶$3MraisedOct 2017 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Courtney BondExecutive Officer, Director, Promoter
- Thomas E. FernandezExecutive Officer, Director, Promoter
- Offering amount
- $3.4M
- Amount sold
- $3M
- Minimum investment
- $50K
- Proceeds to insiders
- $200K
- First sale
- Sep 2017
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Balto Therapeutics raised?
- Balto Therapeutics has disclosed $3M raised across 1 round.
- Where is Balto Therapeutics headquartered?
- Balto Therapeutics is headquartered in New York, US.